These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24011928)

  • 1. Alzheimer's disease in the human eye. Clinical tests that identify ocular and visual information processing deficit as biomarkers.
    Chang LY; Lowe J; Ardiles A; Lim J; Grey AC; Robertson K; Danesh-Meyer H; Palacios AG; Acosta ML
    Alzheimers Dement; 2014 Mar; 10(2):251-61. PubMed ID: 24011928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular biomarkers for early detection of Alzheimer's disease.
    Frost S; Martins RN; Kanagasingam Y
    J Alzheimers Dis; 2010; 22(1):1-16. PubMed ID: 20847434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular indicators of Alzheimer's: exploring disease in the retina.
    Hart NJ; Koronyo Y; Black KL; Koronyo-Hamaoui M
    Acta Neuropathol; 2016 Dec; 132(6):767-787. PubMed ID: 27645291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ocular changes in Alzheimer's disease].
    Kaczmarczyk K; Lubiński W; Karczewicz D
    Klin Oczna; 2007; 109(10-12):482-4. PubMed ID: 18488402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual system manifestations of Alzheimer's disease.
    Kusne Y; Wolf AB; Townley K; Conway M; Peyman GA
    Acta Ophthalmol; 2017 Dec; 95(8):e668-e676. PubMed ID: 27864881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease and retinal neurodegeneration.
    Guo L; Duggan J; Cordeiro MF
    Curr Alzheimer Res; 2010 Feb; 7(1):3-14. PubMed ID: 20205667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging ocular biomarkers of Alzheimer disease.
    van Wijngaarden P; Hadoux X; Alwan M; Keel S; Dirani M
    Clin Exp Ophthalmol; 2017 Jan; 45(1):54-61. PubMed ID: 28147442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related macular degeneration (AMD): Alzheimer's disease in the eye?
    Kaarniranta K; Salminen A; Haapasalo A; Soininen H; Hiltunen M
    J Alzheimers Dis; 2011; 24(4):615-31. PubMed ID: 21297256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The optic neuropathy of Alzheimer's disease.
    Sadun AA
    Metab Pediatr Syst Ophthalmol (1985); 1989; 12(1-3):64-8. PubMed ID: 2770524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The aging eye: common degenerative mechanisms between the Alzheimer's brain and retinal disease.
    Sivak JM
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):871-80. PubMed ID: 23364356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond Vision: A View from Eye to Alzheimer's Disease and Dementia.
    Zheng C; Zeng R; Wu G; Hu Y; Yu H
    J Prev Alzheimers Dis; 2024; 11(2):469-483. PubMed ID: 38374754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optometric management of patients with Alzheimer's disease.
    Baker DR; Mendez MF; Townsend JC; Ilsen PF; Bright DC
    J Am Optom Assoc; 1997 Aug; 68(8):483-94. PubMed ID: 9279048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's Disease Seen through the Eye: Ocular Alterations and Neurodegeneration.
    Romaus-Sanjurjo D; Regueiro U; López-López M; Vázquez-Vázquez L; Ouro A; Lema I; Sobrino T
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of ocular biomarkers as a potential tool for early diagnosis of Alzheimer's disease.
    Singh AK; Verma S
    Indian J Ophthalmol; 2020 Apr; 68(4):555-561. PubMed ID: 32174567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual and Ocular Manifestations of Alzheimer's Disease and Their Use as Biomarkers for Diagnosis and Progression.
    Javaid FZ; Brenton J; Guo L; Cordeiro MF
    Front Neurol; 2016; 7():55. PubMed ID: 27148157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive and structural magnetic resonance imaging features of Lewy body dementia and Alzheimer's disease.
    Rodriguez MJ; Potter E; Shen Q; Barker W; Greig-Custo M; Agron J; Loewenstein D; Duara R
    Alzheimers Dement; 2012 May; 8(3):211-8. PubMed ID: 22546353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and psychometric distinction of frontotemporal and Alzheimer dementias.
    Liscic RM; Storandt M; Cairns NJ; Morris JC
    Arch Neurol; 2007 Apr; 64(4):535-40. PubMed ID: 17420315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual impairment in Alzheimer's disease: a critical review.
    Kirby E; Bandelow S; Hogervorst E
    J Alzheimers Dis; 2010; 21(1):15-34. PubMed ID: 20182034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.